Tag: Clinical trial results
Improved Survival in ES-SCLC with Lurbinectedin/Atezolizumab Combination
A combination of lurbinectedin and atezolizumab has shown significant benefits in overall survival (OS) and progression-free survival (PFS) for patients with extensive-stage small cell...
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib?ROS1 Inhibitor) are Published...
Innovent Biologics Reveals Breakthrough Data from Phase 2 TRUST-I Study of Taletrectinib at 2024 ASCO Annual MeetingSAN FRANCISCO, U.S. and SUZHOU, China - Innovent...